Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients

Journal of Urology

Volumn 155, Issue 3, 1996, Pages 1023-1029

  Schurch, B ^a   Hauri, D ^b   Rodic, B ^b   Curt, A ^b   Meyer, M ^b   Rossier, Alain B ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

bladder, neurogenic; botulinum toxins; spinal cord injuries

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; DETRUSOR DYSSYNERGIA; DRUG EFFECT; DRUG SCREENING; HUMAN; MALE; NEUROGENIC BLADDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINAL CORD INJURY;

EID: 0030065702     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66376-6     Document Type: Article

References (27)

1. Yalla, S. and Fam, B. A.: Spinal cord injury. In: Clinical Neurourology, 2nd ed. Edited by R. J. Krane and M. B. Siroky. Boston: Little, Brown and Co., chapt. 19, pp 319-332, 1991.
2. Vapnek, J. M., Couillard, D. R. and Stone, A. R.: Is sphincterotomy the best management of the spinal cord injured bladder? J. Urol., 151: 961, 1994.
3. Lockhart, J. L., Vorstman, B., Weinstein, D. and Politano, V. A.: Sphincterotomy failure in neurogenic bladder disease. J. Urol., 135: 86, 1986.
4. Chancellor, M. B., Rivas, D. A., Linsenmeyer, T., Abdill, C. A., Ackman, C. F. D., Appell, R. A., Benett, J., Binard, J., Boone, T. B., Chetner, M. P., Defalco, A., Foote, J., Gajewski, J., Green, B., Juma, S., MacMillan, R., Mayo, M., Roehrborn, C. G., Stone, A., Thorndyke, W. C. and Vazquez, A.: Multicenter trial in North America of UroLume urinary sphincter prosthesis. J. Urol., 152: 924, 1994.
5. Perkash, I.: Laser sphincterotomy and ablation of the prostate using a sapphire chisel contact tip firing neodymium: YAG laser. J. Urol., 152: 2020, 1994.
6. Brindley, G. S.: The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia, 32: 795, 1994.
7. Scott, A. B., Kennedy, R. A. and Stubbs, H. A.: Botulinum A toxin injection as a treatment for blepharospasm. Arch. Ophthalmol., 103: 347, 1985.
8. Hesse, S., Lücke, D., Malezic, M., Bertelt, C., Friedrich, H., Gregoric, M. and Mauritz, K. H.: Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J. Neurol. Neurosurg. Psychiatry, 57: 1321, 1994.
9. Schneider, I., Thumfart, W. F., Pototschnig, C. and Eckel, H. E.: Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann. Otol. Rhinol. Laryngol., 103: 31, 1994.
10. Whurr, R., Lorch, M., Fontana, H., Brookes, G., Lees, A. and Marsden, C. D.: The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. J. Neurol. Neurosurg. Psychiatry, 56: 526, 1993.
11. Dykstra, D. D. and Sidi, A. A.: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch. Phys. Med. Rehab., 71: 24, 1990.
12. Schurch, B., Hauri, D., Largo, M., Kreienbühl, B., Meyer, E. and Rossier, A. B.: Effets de la Toxine Botulinique A sur le sphincter strié periurétral des vessies neurogènes. J. Urol., 96: 375, 1990.
13. Yalla, S. V., Rossier, A. B. and Fam, B.: Dyssynergic vesicourethral responses during bladder rehabilitation in spinal cord patients: effects of suprapubic percussion, Crédé method and bethanechol chloride. J. Urol., 115: 575, 1976.
14. Rossier, A. B. and Fam, B. A.: 5-Microtransducer catheter in evaluation of neurogenic bladder function. Urology, 27: 371, 1986.
15. Thyberg, M., Ertzgaard, P., Gylling, M. and Granerus, G.: Effect of nifedipine on cystometry-induced elevation of blood pressure in patients with reflex urinary bladder after high level spinal cord injury. Paraplegia, 32: 308, 1994.
16. Pickett, A. M. and Hambleton, P.: Dose standardisation of botulinum toxin. Lancet, 344: 474, 1994.
17. Dyro, F. M.: Electrophysiology of the lower urinary tract. In: Neurourology and Urodynamics. Principles and Practice. Edited by S. V. Yalla, E. J. McGuire, A. Elbadawi and J. G. Blaivas. New York: Macmillan Publishing Co., chapt. 1, pp. 45-58, 1988.
18. Guttmann, L. and Whitteridge, D.: Effects of bladder distension on autonomic mechanisms after spinal cord injuries. Brain, 70: 361, 1947.
19. Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Südhof, T. C., Niemann, H. and Jahn, R.: Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature, 365: 160, 1993.
20. Carpenter, F. G.: Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats. J. Physiol., 188: 1, 1967.
21. Schurch, B., Yasuda, K. and Rossier, A. B.: Detrusor bladder neck dyssynergia revisited. J. Urol., 152: 2066, 1994.
22. Angaut-Petit, D., Molgò, J., Comella, J. X., Faille, L. and Tabti, N.: Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience, 37: 799, 1990.
23. Olney, R. K., Aminoff, M. J., Gelb, D. J. and Lowenstein, D. H.: Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology, 38: 1780, 1988.
24. Hatheway, C. L. and Dang, C.: Immunogenicity of the neurotoxins of clostridium botulinum. In: Therapy with Botulinum Toxin. Edited by J. Jankovic and M. Hallett. New York: Marcel Dekker, Inc., chapt. 1, pp. 93-108, 1994.
25. Siatkowski, R. M., Tyutyunikov, A., Biglan, A. W., Scalise, D., Genovese, C., Raikow, R. B., Kennerdell, J. S. and Feuer, W. J.: Serum antibody production to botulinum A toxin. Ophthalmology, 100: 1861, 1993.
26. Booth, C. M., Kemplay, S. K. and Brown, M. C.: An antibody to neural cell adhesion molecule impairs motor nerve terminal sprouting in a mouse muscle locally paralysed with botulinum toxin. Neuroscience, 35: 85, 1990.
27. Tsujimoto, T. and Kuno, M.: Calcitonin gene-related peptide prevents disuse-induced sprouting of rat motor nerve terminals. J. Neurosci., 8: 3951, 1988.